Infectious mononucleosis
Clinical trials for Infectious mononucleosis explained in plain language.
Never miss a new study
Get alerted when new Infectious mononucleosis trials appear
Sign up with your email to follow new studies for Infectious mononucleosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a nanoparticle vaccine stop the virus behind mono and some cancers?
Vaccine CompletedThis early-stage trial is testing whether a new vaccine can safely train the immune system to fight Epstein-Barr virus (EBV), which causes infectious mononucleosis and is linked to several cancers. Healthy adults aged 18 to 29, both with and without prior EBV infection, will rece…
Matched conditions: INFECTIOUS MONONUCLEOSIS
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Aug 15, 2026 00:00 UTC
-
Could a vaccine finally stop the 'Kissing Disease'?
Vaccine CompletedThis study tested a new vaccine designed to prevent Epstein-Barr virus (EBV) infection, which causes most cases of infectious mononucleosis (mono). Twenty-five healthy adults aged 18 to 25 who had never been infected with EBV received either the vaccine or a placebo. The goal was…
Matched conditions: INFECTIOUS MONONUCLEOSIS
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC